Business Standard

Sunday, January 05, 2025 | 12:58 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Pharma weight in BSE to touch 5-year low

Cipla, Lupin to be replaced by IndusInd Bank, YES Bank

Pharma weight in BSE to touch 5-yr low
Premium

Abhineet Kumar Mumbai
With drug makers Lupin and Cipla set to be replaced in the S&P BSE Sensex by IndusInd Bank and YES Bank, the weight of the pharmaceutical industry in the index would decline to a five-year low. 

The index, jointly owned by the BSE and the US-based S&P, is a free float, market-weighted stock index of 30 companies. 

“All over the world indices ride on successful stocks as these are made of weights by market capitalisation,” said G Chokkalingam, founder and managing director, Equinomics Research & Advisory.

On Friday, four drug makers together had a 4 per cent weight in the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in